{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:18:27Z","timestamp":1696857507506},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.urology.2014.07.081","type":"journal-article","created":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T22:37:05Z","timestamp":1418942225000},"page":"165-171","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk"],"prefix":"10.1016","volume":"85","author":[{"given":"A. Karim","family":"Kader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jielin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.07.081_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2014.07.081_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2014.07.081_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2014.07.081_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A\u00a0risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.081_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2014.07.081_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa075819","article-title":"Cumulative association of five genetic variants with prostate cancer","volume":"358","author":"Zheng","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.eururo.2012.05.006","article-title":"Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial","volume":"62","author":"Kader","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.081_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2011.01.017","article-title":"Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study","volume":"60","author":"Aly","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.081_bib12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/pros.21208","article-title":"Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation","volume":"70","author":"Kim","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2014.07.081_bib13","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1056\/NEJMsa0708739","article-title":"Polygenes, risk prediction, and targeted prevention of breast cancer","volume":"358","author":"Pharoah","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.urology.2014.07.081_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.urology.2014.07.081_bib16","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1158\/1078-0432.CCR-08-2190","article-title":"Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features","volume":"15","author":"Fitzgerald","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2014.07.081_bib17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/pros.21002","article-title":"Estimation of absolute risk for prostate cancer using genetic markers and family history","volume":"69","author":"Xu","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2014.07.081_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pros.20887","article-title":"Clinical utility of five genetic variants for predicting prostate cancer risk and mortality","volume":"69","author":"Salinas","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2014.07.081_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.eururo.2011.10.047","article-title":"Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men","volume":"61","author":"Klein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.081_bib20","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.ejca.2011.06.055","article-title":"False-positive screening results in the European randomized study of screening for prostate cancer","volume":"47","author":"Kilpelainen","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2014.07.081_bib21","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level\u00a0\u22644.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.081_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cncr.25568","article-title":"Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50","volume":"117","author":"Lilja","year":"2011","journal-title":"Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514010899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429514010899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T02:04:03Z","timestamp":1598580243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429514010899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0090429514010899"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.07.081","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2014.07.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}